Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Frankfurt - Delayed Quote EUR

Indivior PLC (2IVB.F)

Compare

8.15

-0.75

(-8.43%)

At close: February 21 at 10:45:40 AM GMT+1

Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Indivior ( LON:INDV ) Full Year 2024 Results Key Financial Results Revenue: US$1.19b (up 8.7% from FY 2023). Net loss...

Simply Wall St. yesterday

INDV
Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ...

Indivior PLC (INDV) reports a 20% increase in SUBLOCADE net revenue for 2024, while implementing significant cost-saving measures to enhance financial flexibility.

GuruFocus.com 2 days ago

INDV
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat

Indivior Plc (NASDAQ:INDV) stock plunged following the company’s fiscal year 2025 guidance that fell short of Street expectations. Addiction and mental illnesses-focused Indivior reported fourth-quarter sales of $298 million, up 2% year over year, beating the consensus of $259.3 million. The London-based healthcare firm reported adjusted EPS of 32 cents, down from 43 a year ago, beating the consensus of 21 cents. In the fourth quarter, adjusted operating profit remained unchanged at $66 million,

Benzinga 2 days ago

INDV
Indivior PLC (INDV) Q4 Earnings Meet Estimates

Indivior (INDV) delivered earnings and revenue surprises of 0% and 13.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 days ago

INDV
Indivior Announces FY and Q4 2024 Financial Results

Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending December 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.

PR Newswire 3 days ago

INDV
Stocks to watch this week: Alibaba, Walmart, HSBC, Rio Tinto and Lloyds

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 8 days ago

RIO

RTNTF

RTPPF
Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Indivior (INDV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 9 days ago

INDV

KPTI
Here’s Summers Value Partners’ Investment Thesis for Indivior (INDV)

Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Summers Value Fund LP returned a net1 return of 27.4% in 2024 outperforming 11.3% return for its primary benchmark, the Russell 2000 Index ETF (IWM). The fund also outperformed its secondary […]

Insider Monkey 22 days ago

INDV

^RUT
Great week for Indivior PLC (LON:INDV) institutional investors after losing 23% over the previous year

Key Insights Institutions' substantial holdings in Indivior implies that they have significant influence over the...

Simply Wall St. last month

INDV
Indivior (LON:INDV) shareholder returns have been enviable, earning 366% in 5 years

For many, the main point of investing in the stock market is to achieve spectacular returns. While the best companies...

Simply Wall St. 2 months ago

INDV
Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...

Despite a dip in revenue, Addex Therapeutics Ltd (ADXN) advances its drug development programs and strengthens its financial position through strategic collaborations.

GuruFocus.com 2 months ago

INDV
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

Indivior PLC (Nasdaq/LSE: INDV) last week shared results from a randomized, open-label sub-study in opioid-dependent participants seeking treatment, (NCT04995029) that demonstrates rapid initiation (RI) with SUBLOCADE® (buprenorphine extended-release injection) for the treatment of OUD significantly improves treatment retention compared to standard initiation (SI). RI with SUBLOCADE in a single day may reduce barriers to treatment and improve patient retention especially those who frequently inj

PR Newswire 3 months ago

INDV
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior

Indivior PLC (NASDAQ / LSE: INDV) the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a letter from Oaktree Capital Management LP ("Oaktree") to the Board of Indivior.

PR Newswire 3 months ago

INDV
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month

Indivior PLC (Nasdaq/LSE: INDV), in recognizing Substance Abuse Prevention Month, provides an update on key findings from the last year that demonstrate the importance of access to medications for the treatment of opioid use disorder (MOUD) and the effectiveness and safety of SUBLOCADE® in the treatment of OUD. These data add to the growing body of evidence that SUBLOCADE can improve outcomes, such as abstinence, retention, and recovery in persons with OUD.

PR Newswire 3 months ago

INDV
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ...

Indivior PLC (INDV) reports a 13% increase in total net revenue and a 62% rise in adjusted operating profit, while navigating competitive pressures and strategic cost reductions.

GuruFocus.com 3 months ago

INDV
Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates

Indivior (INDV) delivered earnings and revenue surprises of 38.46% and 1.57%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 3 months ago

INDV
Indivior Announces Q3 2024 Financial Results

Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending September 30, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.

PR Newswire 3 months ago

INDV
Two Seas Capital LP Increases Stake in Indivior PLC

On October 15, 2024, Two Seas Capital LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 400,001 shares of Indivior PLC (NASDAQ:INDV), a specialty drug manufacturing company. This transaction has increased the firm's total holdings in Indivior to 13,030,027 shares, marking a substantial influence on its investment strategy. Two Seas Capital LP (Trades, Portfolio), based at 1 Read Court, New York, NY 10580, is a prominent investment firm known for its strategic positions in the healthcare and utilities sectors.

GuruFocus.com 4 months ago

INDV
Indivior price target lowered to $16 from $20 at Craig-Hallum

Craig-Hallum lowered the firm’s price target on Indivior to $16 from $20 and keeps a Buy rating on the shares. While Q3 pre-released results were relatively in-line and ahead of expectations on the overall top-line, FY24 guidance was revised lower in what the firm calls “a disappointing update.” The company lowering FY24 net revenue guidance was “entirely driven by worsening fundamentals for Sublocade,” notes the analyst, who calls Sublocade “the chief value driver for Indivior.” There is hope f

TipRanks 4 months ago

INDV
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and ...

Indivior PLC (INDV) outlines strategic initiatives to bolster SUBLOCADE's market position amidst increased competition and evolving market dynamics.

GuruFocus.com 4 months ago

INDV

Performance Overview

Return	2IVB.F	FTSE 100
YTD	-30.34%	+5.95%
1-Year	-47.42%	+13.01%
3-Year	-49.75%	+15.70%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Indivior PLC (2IVB.F)

Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ...

European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat

Indivior PLC (INDV) Q4 Earnings Meet Estimates

Indivior Announces FY and Q4 2024 Financial Results

Stocks to watch this week: Alibaba, Walmart, HSBC, Rio Tinto and Lloyds

Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Here’s Summers Value Partners’ Investment Thesis for Indivior (INDV)

Great week for Indivior PLC (LON:INDV) institutional investors after losing 23% over the previous year

Indivior (LON:INDV) shareholder returns have been enviable, earning 366% in 5 years

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior

Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month

Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ...

Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates

Indivior Announces Q3 2024 Financial Results

Two Seas Capital LP Increases Stake in Indivior PLC

Indivior price target lowered to $16 from $20 at Craig-Hallum

Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and ...

Performance Overview